Results 21 to 30 of about 8,148 (212)

Cytokine Induced Killer (CIK) Cells Based Adoptive Immunotherapy

open access: yesJournal of Gandaki Medical College, 2018
Cytokine induced killer (CIK) cells has been increasingly used in adoptive immunotherapy against various cancers and viral infections. This review summarizes the basic overview of CIK cells as a therapeutic immunocyte.
S Timalsena, P P Lamichhane
doaj   +3 more sources

Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial [PDF]

open access: yesCancer Immunology, Immunotherapy
Background Most adjuvant therapies for hepatocellular carcinoma (HCC) have failed except for autologous cytokine-induced killer (CIK) therapy, which prolonged recurrence-free survival (RFS) in a previously reported randomized controlled trial (RCT) and ...
Hyunjae Shin   +16 more
doaj   +2 more sources

THERMAL COMFORT SIMULATION ON CIK DITIRO CORRIDOR

open access: yesDIMENSI (Journal of Architecture and Built Environment), 2019
Surface materials that turn into hard surface material and lack of vegetations are some of the effects of rapid development that can affect the micro climate in urban areas. This happened on Cik Ditiro corridor in the city of Yogyakarta which had quite dense activities, this was marked by various functions of land use and human activities throughout ...
Septian Eka Prayoga, Arif Kusumawanto
openaire   +4 more sources

Synergistic integration of histone deacetylase inhibitors apparently enhances the cytokine‐induced killer cell efficiency in multiple myeloma via the NKG2D pathway [PDF]

open access: yesClinical & Translational Immunology
Objectives The rapid recognition of epigenetic manipulation's potential in restricting cancer cell capabilities spurred translational initiatives, including histone deacetylase inhibitors (HDACis).
Jingjing Pu   +4 more
doaj   +2 more sources

Cytokine-induced killer cell treatment is superior to chemotherapy alone in esophageal cancer

open access: yesPathology and Oncology Research, 2023
Background: The therapeutic efficacy of cytokine-induced killer (CIK) cells versus dendritic cells (DC) co-cultured with CIK cells (DC-CIK) in treating esophageal cancer (EC) remains unclear due to the absence of a direct comparison of these two regimens.
Jiayang Sun   +3 more
doaj   +1 more source

NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation

open access: yesFrontiers in Immunology, 2021
Cytokine-induced killer (CIK) cells are an ex vivo expanded heterogeneous cell population with an enriched NK-T phenotype (CD3+CD56+). Due to the convenient and relatively inexpensive expansion capability, together with low incidence of graft versus host
Xiaolong Wu   +7 more
doaj   +1 more source

Immunophenotype and antitumor activity of cytokine-induced killer cells from patients with hepatocellular carcinoma

open access: yesPLoS ONE, 2023
Background Cytokine-induced killer (CIK) cells are heterogeneous lymphocytes from human peripheral blood mononucleated cells (PBMCs) co-cultured with several cytokines.
Chan-Keng Yang   +6 more
doaj   +2 more sources

Optimizing tumor-associated antigen-stimulated autologous dendritic cell and cytokine-induced killer cell coculture to enhance cytotoxicity for cancer immunotherapy in manufacturing

open access: yesBMC Immunology, 2023
Background Dendritic Cell Cytokine-induced killer cell (DC-CIK) coculture treatment in cancer immunotherapy has been shown to be effective. However, the cost of DC- CIK therapy is prohibitive for many patients, and the lack of standard manufacturing ...
Yi-Yen Lee   +8 more
doaj   +1 more source

[Researche advances on CIK cells and their clinical use in lung cancer].

open access: yesZhongguo fei ai za zhi = Chinese journal of lung cancer, 2011
As the leading cause of cancer-related death among human beings, lung cancer seriously threats peoples' health all over the world. Cytokine-induced killer cells (CIK) is a new kind of adaptive immune cells characterized by its dramatic proliferation ability and cytotoxicity, non-major histocompatibility antigens (MHC) restriction and low side effects ...
Hu LUO, Xiangdong ZHOU
openaire   +4 more sources

Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK

open access: yesChinese Journal of Cancer, 2010
Cytokine-induced killer (CIK) cells and autologous dendritic cells-CIK (DC-CIK) cells co-cultured with autologous dendritic cells (DCs) and CIK cells are commonly used for immunotherapy recently. We compared the anti-tumor immune response of CIK cells, autologous DC-CIK cells, and semi-allogeneic DC-CIK cells to explore a more effective anti-tumor ...
Qi-Jing, Wang   +14 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy